One month of yeast protein supplementation in mice significantly improved muscle strength and bone mineral density while downregulating key cellular aging markers including p16, p53, p21, and γ-H2AX. The intervention also enriched beneficial gut bacteria, particularly Akkermansia, which correlated with the observed health improvements. This finding adds compelling evidence to the emerging understanding that protein quality, not just quantity, plays a crucial role in healthy aging. Yeast protein's unique bioactive compound profile may offer advantages over traditional protein sources for age-related muscle preservation. The simultaneous improvement in musculoskeletal function and reduction in senescence markers suggests yeast protein could address multiple aging pathways concurrently. However, the one-month intervention period in mice represents a significant limitation for translating these findings to human longevity applications. The gut microbiota changes, particularly the Akkermansia enrichment, align with established research linking this bacteria to metabolic health and longevity. While promising, this represents incremental progress in the protein and aging field rather than a paradigm shift, requiring human trials to establish practical applications for muscle and bone health in aging adults.